FDA Drug Application (203259) for LAMIVUDINE AND ZIDOVUDINE by HETERO LABS LTD V

Back to FDA Applications sponsored by HETERO LABS LTD V

Application Number203259
Product Number001
FormTABLET;ORAL
Dosage150MG;300MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLAMIVUDINE AND ZIDOVUDINE
Active IngredientLAMIVUDINE; ZIDOVUDINE

Active IngredientCount
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient ZIDOVUDINE17


Back to FDA Applications sponsored by HETERO LABS LTD V